Remdesivir is very difficult and expensive to synthesize, and it’s patented by Gilead. HCQ is dirt cheap and generic. Of course we should be testing anything th

Remdesivir is very difficult and expensive to synthesize, and it’s patented by Gilead. HCQ is dirt cheap and generic. Of course we should be testing anything that shows enough promise and has a well understood safety profile, but it’s obvious why the cheap generic drug working would be better.